Literature DB >> 19880876

Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.

Begoña Benito1, Stanley Nattel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880876      PMCID: PMC2790241          DOI: 10.1113/jphysiol.2009.181339

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  30 in total

1.  Calcineurin and human heart failure.

Authors:  H W Lim; J D Molkentin
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

2.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

Review 3.  The athlete's heart: a contemporary appraisal of the 'Morganroth hypothesis'.

Authors:  Louise H Naylor; Keith George; Gerry O'Driscoll; Daniel J Green
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

4.  Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.

Authors:  Jan B Bartholomeu; Andréa S Vanzelli; Natale P L Rolim; Julio C B Ferreira; Luiz R G Bechara; Leonardo Y Tanaka; Kaleizu T Rosa; Márcia M Alves; Alessandra Medeiros; Katt C Mattos; Marcele A Coelho; Maria C Irigoyen; Eduardo M Krieger; Jose E Krieger; Carlos E Negrão; Paulo R Ramires; Silvia Guatimosim; Patricia C Brum
Journal:  J Mol Cell Cardiol       Date:  2008-05-27       Impact factor: 5.000

5.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

6.  Altered peripheral noradrenergic activity in intact and sinoaortic denervated Dahl rats.

Authors:  J D Peuler; K P Patel; D A Morgan; C A Whiteis; D D Lund; B J Pardini; P G Schmid
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

7.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

Authors:  S Engelhardt; L Hein; F Wiesmann; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 8.  Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity.

Authors:  Patrick J Mueller
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-04       Impact factor: 2.557

9.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

Authors:  J N Cohn; T B Levine; M T Olivari; V Garberg; D Lura; G S Francis; A B Simon; T Rector
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

10.  Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.

Authors:  Dario Leosco; Giuseppe Rengo; Guido Iaccarino; Luca Golino; Massimo Marchese; Francesca Fortunato; Carmela Zincarelli; Emma Sanzari; Michele Ciccarelli; Gennaro Galasso; Giovanna Giuseppina Altobelli; Valeria Conti; Gianfranco Matrone; Vincenzo Cimini; Nicola Ferrara; Amelia Filippelli; Walter J Koch; Franco Rengo
Journal:  Cardiovasc Res       Date:  2007-12-18       Impact factor: 10.787

View more
  2 in total

1.  Exercise training, inflammation and heart failure: working out to cool down.

Authors:  Eduard Guasch; Begoña Benito; Stanley Nattel
Journal:  J Physiol       Date:  2010-07-15       Impact factor: 5.182

2.  Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity.

Authors:  Andrey J Serra; Marília H H Santos; Danilo S Bocalini; Ednei L Antônio; Rozeli F Levy; Alexandra A Santos; Maria L Higuchi; José A Silva; Flávio C Magalhães; Valério G Baraúna; José E Krieger; Paulo J F Tucci
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.